IP Library › Granted Patent US 7,341,994
Granted Patent B2
US 7,341,994 · App. 10/257,950 · Granted Mar 11, 2008

GD3-mimetic peptides

Assignee: Otsuka Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,341,994
App. No.
10/257,950
Granted
Mar 11, 2008
Kind
B2
Abstract

GD3-Mimetic peptides which contain an amino acid sequence represented by any of SEQ ID NOS: 1 to 4 or an amino acid sequence derived therefrom by substitution, deletion, addition, or insertion of one or more amino acid residues and attaining specific binding to an anti-GD3 antibody; and medicinal compositions containing the same.

Claims (2)

1. An isolated peptide which specifically binds to an anti-GD-3 antibody and consists of SEQ ID NO:4.

2. A composition comprising the isolated peptide of claim 1 and a pharmaceutically acceptable carrier.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2002
From: ISHIKAWA, DAI; OGINO, KOICHI; TAKI, TAKAO
To: OTSUKA PHARMACEUTICAL CO., LTD.
Reel/Frame 013488/0001 →
Priority Claims (1)
JP 2000-124259 · Apr 25, 2000 · national
Continuity (1)
Related Publication 20060058226A1 · Mar 16, 2006